NxStage(R) Ranked 14th Fastest Growing Company in North America on Deloitte's 2008 Technolog... (s to a significant portion of the compan...)

NxStage(R) Ranked 14th Fastest Growing Company in North America on Deloitte's 2008 Technology Fast 500

Date:11/21/2008

s to a significant portion of the company's operating revenues or devote a significant proportion of revenues to research and development of technology. Using other companies' technology or intellectual property in a unique way does not qualify. Base-year operating revenues must be at least $50,000 USD or $75,000 CD, and current-year operating revenues must be at least $5 million USD or CD. Companies must be in business a minimum of five years, and they must be headquartered within North America.

About NxStage Medical

NxStage Medical, Inc. (Nasdaq: NXTM) is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative dialysis systems for the treatment of end-stage renal disease, or ESRD, and acute kidney failure. For more information on NxStage and its products, please visit the company's website at http://www.nxstage.com.

About Deloitte

As used in this document, "Deloitte" means Deloitte LLP. Please see http://www.deloitte.com/about for a detailed description of the legal structure of Deloitte LLP and its subsidiaries.

Forward-Looking Statements

This release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this release that are not clearly historical in nature are forward-looking, and the words "anticipate," "believe," "expect," "estimate," "plan," and similar expressions are generally intended to identify forward-looking statements. All forward-looking statements involve risks, uncertainties and contingencies, many of which are beyond NxStage's control, which may cause actual results, performance, or achiev
'/>"/>

0

GOOD

Page: 1 2 3
Related medicine news :

1. NxStage(R) Achieves Milestone with 3,000 End-Stage Renal Disease Patients Receiving Daily Home Hemodialysis Therapy
2. Emil Paganini, MD, Joins NxStage(R) as Critical Care Medical Advisor
3. NxStage(R) Medical to Report Fourth Quarter & Full Year 2007 Financial Results on Tuesday, February 12th
4. U.S. News & World Report Names Kaiser Permanente Top-Ranked Health Plan in Georgia
5. HTH Worldwide Ranked Number 435 Fastest Growing Company in North America on Deloittes 2008 Technology Fast 500
6. Health Alliance Plans Medicare HMO is Top-Ranked Medicare Plan in Michigan and Top 25 in U.S.
7. Preferred Care Gold Ranked Number One Medicare Advantage Health Plan Nationally In U.S. News & World Report/NCQA Americas Best Health Plans 2008 Listing
8. Health Plan of Michigan Ranked Among Nations Best Medicaid Health Plans in 2008
9. Cadient Group Ranked 34th in Deloittes Fast 50 Program for Greater Philadelphia
10. HTH Worldwide Ranked Number 21 in Deloittes Fast 50 Program for Greater Philadelphia
11. Accuray Incorporated Ranked Fifth in Deloittes Technology Fast 50 Program for Silicon Valley Scientific/Medical Equipment, and Biotechnology Companies

Post Your Comments:

NxStage(R) Ranked 14th Fastest Growing Company in North America on Deloitte's 2008 Technolog...(s to a significant portion of the compan...),Health